Page last updated: 2024-10-30

lamotrigine and Unverricht-Lundborg Syndrome

lamotrigine has been researched along with Unverricht-Lundborg Syndrome in 1 studies

Unverricht-Lundborg Syndrome: An autosomal recessive condition characterized by recurrent myoclonic and generalized seizures, ATAXIA, slowly progressive intellectual deterioration, DYSARTHRIA, and intention tremor. Myoclonic seizures are severe and continuous, and tend to be triggered by movement, stress, and sensory stimuli. The age of onset is between 8 and 13 years, and the condition is relatively frequent in the Baltic region, especially Finland. (From Menkes, Textbook of Child Neurology, 5th ed, pp109-110)

Research Excerpts

ExcerptRelevanceReference
"Persistence of invalidating action myoclonus is a major problem."2.72Lack of efficacy and potential aggravation of myoclonus with lamotrigine in Unverricht-Lundborg disease. ( Crespel, A; Gelisse, P; Genton, P, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Genton, P1
Gelisse, P1
Crespel, A1

Trials

1 trial available for lamotrigine and Unverricht-Lundborg Syndrome

ArticleYear
Lack of efficacy and potential aggravation of myoclonus with lamotrigine in Unverricht-Lundborg disease.
    Epilepsia, 2006, Volume: 47, Issue:12

    Topics: Acute Disease; Adult; Age of Onset; Anticonvulsants; Dose-Response Relationship, Drug; Drug Therapy,

2006